Correlation Between Magenta Therapeutics and Achilles Therapeutics
Can any of the company-specific risk be diversified away by investing in both Magenta Therapeutics and Achilles Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Magenta Therapeutics and Achilles Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Magenta Therapeutics and Achilles Therapeutics PLC, you can compare the effects of market volatilities on Magenta Therapeutics and Achilles Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Magenta Therapeutics with a short position of Achilles Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Magenta Therapeutics and Achilles Therapeutics.
Diversification Opportunities for Magenta Therapeutics and Achilles Therapeutics
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between Magenta and Achilles is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Magenta Therapeutics and Achilles Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Achilles Therapeutics PLC and Magenta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Magenta Therapeutics are associated (or correlated) with Achilles Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Achilles Therapeutics PLC has no effect on the direction of Magenta Therapeutics i.e., Magenta Therapeutics and Achilles Therapeutics go up and down completely randomly.
Pair Corralation between Magenta Therapeutics and Achilles Therapeutics
Given the investment horizon of 90 days Magenta Therapeutics is expected to generate 0.71 times more return on investment than Achilles Therapeutics. However, Magenta Therapeutics is 1.4 times less risky than Achilles Therapeutics. It trades about 0.16 of its potential returns per unit of risk. Achilles Therapeutics PLC is currently generating about 0.03 per unit of risk. If you would invest 72.00 in Magenta Therapeutics on August 31, 2024 and sell it today you would earn a total of 10.00 from holding Magenta Therapeutics or generate 13.89% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 8.56% |
Values | Daily Returns |
Magenta Therapeutics vs. Achilles Therapeutics PLC
Performance |
Timeline |
Magenta Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Achilles Therapeutics PLC |
Magenta Therapeutics and Achilles Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Magenta Therapeutics and Achilles Therapeutics
The main advantage of trading using opposite Magenta Therapeutics and Achilles Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Magenta Therapeutics position performs unexpectedly, Achilles Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Achilles Therapeutics will offset losses from the drop in Achilles Therapeutics' long position.Magenta Therapeutics vs. Assembly Biosciences | Magenta Therapeutics vs. Instil Bio | Magenta Therapeutics vs. Nuvation Bio | Magenta Therapeutics vs. Achilles Therapeutics PLC |
Achilles Therapeutics vs. Assembly Biosciences | Achilles Therapeutics vs. Spero Therapeutics | Achilles Therapeutics vs. Instil Bio | Achilles Therapeutics vs. Nuvation Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |